Sriharsha Tella

Concepts (119)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholangiocarcinoma
2
2020
20
0.860
Why?
Bile Duct Neoplasms
2
2020
39
0.850
Why?
Paraganglioma, Extra-Adrenal
1
2020
3
0.730
Why?
Adrenergic Antagonists
1
2020
4
0.730
Why?
Bile Ducts, Extrahepatic
1
2020
3
0.710
Why?
Heart Neoplasms
1
2020
33
0.710
Why?
CA-19-9 Antigen
1
2020
5
0.710
Why?
Cardiac Imaging Techniques
1
2020
35
0.700
Why?
Biliary Tract Neoplasms
1
2020
17
0.700
Why?
Neoplasm Staging
8
2020
800
0.700
Why?
Salvage Therapy
1
2020
82
0.670
Why?
Molecular Targeted Therapy
1
2020
170
0.640
Why?
Adrenocortical Carcinoma
1
2018
4
0.640
Why?
Adrenal Cortex Neoplasms
1
2018
5
0.640
Why?
Antineoplastic Agents
3
2020
1070
0.620
Why?
Leukemia, Mast-Cell
1
2018
1
0.620
Why?
Mast-Cell Sarcoma
1
2018
1
0.620
Why?
Mastocytosis, Systemic
1
2018
3
0.610
Why?
History, Ancient
1
2018
25
0.610
Why?
Hypophosphatemia
1
2017
6
0.600
Why?
Carcinoma, Hepatocellular
1
2020
163
0.600
Why?
Fibroblast Growth Factors
1
2017
51
0.590
Why?
Hospitals
1
2019
265
0.580
Why?
Anemia, Iron-Deficiency
1
2017
34
0.580
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
468
0.550
Why?
Liver Neoplasms
1
2020
334
0.540
Why?
Melanoma
1
2019
335
0.530
Why?
Cardiac Surgical Procedures
1
2020
450
0.530
Why?
Pancreatic Neoplasms
1
2019
332
0.520
Why?
Skin Neoplasms
1
2019
375
0.510
Why?
Prognosis
8
2020
2093
0.480
Why?
Carcinoma, Squamous Cell
1
2019
629
0.460
Why?
Aged, 80 and over
9
2019
4848
0.370
Why?
Aged
12
2020
14862
0.360
Why?
Survival Rate
4
2020
1056
0.340
Why?
Survival Analysis
4
2018
714
0.340
Why?
Young Adult
9
2019
5717
0.330
Why?
Middle Aged
13
2020
21147
0.320
Why?
Histiocytic Sarcoma
2
2018
3
0.310
Why?
Humans
20
2020
68618
0.300
Why?
SEER Program
5
2019
153
0.300
Why?
Adolescent
9
2019
8912
0.300
Why?
United States
11
2019
7367
0.280
Why?
Female
14
2020
38074
0.280
Why?
Incidence
6
2019
1603
0.260
Why?
Adult
11
2019
21403
0.260
Why?
Male
12
2020
37321
0.240
Why?
Neoplasm Grading
3
2019
111
0.240
Why?
Neoplasms, Second Primary
2
2018
62
0.190
Why?
United States Food and Drug Administration
2
2019
131
0.190
Why?
Biliary Tract Surgical Procedures
1
2020
9
0.180
Why?
Margins of Excision
1
2020
15
0.180
Why?
Multimodal Imaging
1
2020
62
0.170
Why?
Radiotherapy
1
2020
86
0.170
Why?
Langerhans Cell Sarcoma
1
2019
1
0.170
Why?
Hospital Bed Capacity
1
2019
15
0.170
Why?
Filgrastim
1
2019
22
0.170
Why?
Chemotherapy, Adjuvant
1
2019
129
0.160
Why?
Propensity Score
1
2019
117
0.160
Why?
Radiotherapy, Adjuvant
1
2019
125
0.160
Why?
Databases, Factual
2
2018
622
0.160
Why?
Neutropenia
1
2019
72
0.160
Why?
Biosimilar Pharmaceuticals
1
2019
25
0.160
Why?
Drug Industry
1
2019
54
0.160
Why?
Long Term Adverse Effects
1
2018
6
0.160
Why?
Histiocytes
1
2018
8
0.160
Why?
Leukemia, T-Cell
1
2018
21
0.160
Why?
Lymphoma, Extranodal NK-T-Cell
1
2018
1
0.160
Why?
Lymph Nodes
1
2020
258
0.160
Why?
Lymphoma, T-Cell
1
2018
19
0.160
Why?
Drug Costs
1
2019
87
0.160
Why?
Cost Savings
1
2019
110
0.160
Why?
Behavioral Symptoms
1
2018
32
0.160
Why?
Immunotherapy
1
2020
215
0.160
Why?
Fluoroquinolones
1
2018
49
0.150
Why?
Lymphoma, Large B-Cell, Diffuse
1
2018
47
0.150
Why?
Treatment Outcome
5
2020
7029
0.150
Why?
Suicide
1
2018
116
0.150
Why?
Genetic Predisposition to Disease
1
2020
786
0.140
Why?
Predictive Value of Tests
1
2020
1465
0.140
Why?
Carcinoma, Non-Small-Cell Lung
1
2019
300
0.130
Why?
Registries
1
2019
733
0.130
Why?
Multivariate Analysis
1
2018
1046
0.130
Why?
Child
4
2018
6405
0.120
Why?
Models, Statistical
1
2018
448
0.120
Why?
T-Lymphocytes
1
2018
597
0.120
Why?
Child, Preschool
2
2018
3187
0.120
Why?
Practice Patterns, Physicians'
1
2018
504
0.110
Why?
Combined Modality Therapy
3
2019
951
0.100
Why?
Retrospective Studies
3
2019
7277
0.100
Why?
Infant, Newborn
1
2018
2455
0.100
Why?
Infant
1
2018
2891
0.100
Why?
Lung Neoplasms
1
2019
1173
0.090
Why?
Risk Factors
1
2020
5731
0.090
Why?
Breast Neoplasms
1
2018
1536
0.080
Why?
Neoplasm Metastasis
2
2019
306
0.070
Why?
Kaplan-Meier Estimate
2
2019
536
0.070
Why?
Disease Management
2
2019
248
0.070
Why?
Population Surveillance
2
2019
285
0.070
Why?
Proportional Hazards Models
2
2019
792
0.070
Why?
Hematologic Agents
1
2019
11
0.040
Why?
Public Health Surveillance
1
2019
18
0.040
Why?
Japan
1
2019
68
0.040
Why?
Hospitals, Low-Volume
1
2018
12
0.040
Why?
Hospitals, High-Volume
1
2018
18
0.040
Why?
Europe
1
2019
196
0.040
Why?
Canada
1
2019
267
0.040
Why?
Adverse Drug Reaction Reporting Systems
1
2018
42
0.040
Why?
Epidemiological Monitoring
1
2017
23
0.040
Why?
Sex Distribution
1
2018
274
0.040
Why?
Suicidal Ideation
1
2018
106
0.040
Why?
Socioeconomic Factors
1
2019
955
0.030
Why?
Delivery of Health Care
1
2019
445
0.030
Why?
Prevalence
1
2018
1619
0.030
Why?
Risk Assessment
1
2018
2007
0.020
Why?
Follow-Up Studies
1
2018
3259
0.020
Why?
Anti-Bacterial Agents
1
2018
1026
0.020
Why?
Time Factors
1
2018
4655
0.020
Why?
Neoplasms
1
2019
1667
0.020
Why?
Tella's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (119)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_